Chanda Sanjay

AN2 Therapeutics, Inc. · Chief Development Officer

Chanda Sanjay is listed in public filings as officer: Chief Development Officer. This Chanda Sanjay insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include AN2 Therapeutics, Inc. (ANTX). Investors use Chanda Sanjay's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
AN2 Therapeutics, Inc.ANTX$6.0k6k sharesSellJan 6, 2026$1.01--